Catalyst Wire Dossier Catalyst Wire Dossier

Sprimeo HCT

· Novartis Europharm Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sprimeo HCT, covering 2012-08-28 to 2012-08-28. Get the full timeline:

Most recent: EMA Withdrawn: Sprimeo HCT (aliskiren;hydrochlorothiazide) — Novartis Europharm Ltd.

See pricing